Soleno Therapeutics
SLNO
#4324
Rank
A$3.95 B
Marketcap
A$75.91
Share price
0.00%
Change (1 day)
-42.34%
Change (1 year)

Earnings for Soleno Therapeutics (SLNO)

Earnings in 2026 (TTM): A$0.15 Billion

According to Soleno Therapeutics's latest financial reports the company's current earnings are A$0.28 Billion. In 2025 the company made an earning of A$37.75 Million, an increase over its 2024 earnings that were of -A$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soleno Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.15 B311.72%
2025 A$37.75 M-115.52%
2024 -A$0.25 Billion339.22%
2023 -A$55.38 Million54.01%
2022 -A$35.96 Million-22.16%
2021 -A$46.2 Million0.97%
2020 -A$45.76 Million37.73%
2019 -A$33.22 Million96.94%
2018 -A$16.87 Million21.69%
2017 -A$13.87 Million-23.69%
2016 -A$18.17 Million-20.82%
2015 -A$22.94 Million86%
2014 -A$12.34 Million829.91%
2013 -A$1.33 Million